Journal of neuro-oncology

Keyphrases

Publications

volume 169, number 2, 2024

Umberto Battistin, Ryan Nguyen, Abdul Karim Ghaith, Victor Gabriel El-Hajj, Fatima Soltan, Sara Ghaith, Joshua H Weinberg, Adrian Elmi-Terander, Andrew J Grossbach, Oluwaseun O Akinduro
The impact of socioeconomic determinants on the access to care and survival in patients with spinal chordomas- a national cancer database analysis. Journal of neuro-oncology 169 (2) (2024)
Jacopo Bellomo, Anna Maria Zeitlberger, Luis Padevit, Vittorio Stumpo, Meltem Gönel, Jorn Fierstra, Nathalie Nierobisch, Regina Reimann, Isabell Witzel, Michael Weller, Emilie Le Rhun, Oliver Bozinov, Luca Regli, Marian Christoph Neidert, Carlo Serra, Stefanos Voglis
Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis. Journal of neuro-oncology 169 (2) (2024)
A P Landry, J A Zuccato, V Patil, M R Voisin, J Z Wang, Y Ellenbogen, C Gui, A Ajisebutu, T Kislinger, F Nassiri, G Zadeh
Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours. Journal of neuro-oncology 169 (2) (2024)
Anuraag Punukollu, Brodus Franklin, Felipe Gutierrez Pineda, Kim Wouters, Lucca Palavani, David Hung-Chi Pan, Hsien-Chung Chen
Gamma knife radiosurgery for orbital cavernous hemangioma: a systematic review and single-arm meta-analysis. Journal of neuro-oncology 169 (2) (2024)
Shuhei Yamada, Toru Umehara, Kyuto Sonehara, Noriyuki Kijima, Shuhei Kawabata, Koji Takano, Tomoki Kidani, Ryuichi Hirayama, Hideyuki Arita, Yoshiko Okita, Manabu Kinoshita, Naoki Kagawa, Toshiyuki Fujinaka, Toshiaki Fujita, Akatsuki Wakayama, null null, Koichi Matsuda, Yukinori Okada, Haruhiko Kishima
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study. Journal of neuro-oncology 169 (2) (2024)
Sabine Wagner, Christian Ewald, Diana Freitag, Karl-Heinz Herrmann, Arend Koch, Johannes Bauer, Thomas J Vogl, André Kemmling, Hubert Gufler
Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI. Journal of neuro-oncology 169 (2) (2024)
Sophie Shih-Yüng Wang, Gerhard Horstmann, Albertus van Eck, Marcos Tatagiba, Georgios Naros
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma. Journal of neuro-oncology 169 (2) (2024)
Matthew C Hocking, Robert T Schultz, Benjamin E Yerys, Jane E Minturn, Peter Fantozzi, John D Herrington
White matter connectivity and social functioning in survivors of pediatric brain tumor. Journal of neuro-oncology 169 (2) (2024)
Chiara Ghezzi, Benjamin M Ellingson, Albert Lai, Jie Liu, Jorge R Barrio, Ernest M Wright
Effect of Jardiance on glucose uptake into astrocytomas. Journal of neuro-oncology 169 (2) (2024)
Souhir Guidara, Antoine Seyve, Delphine Poncet, Camille Leonce, Pierre-Paul Bringuier, Anne McLeer, Dominik Sturm, Stéphanie Cartalat, Thiebaud Picart, Anthony Ferrari, Jürgen Hench, Stephan Frank, David Meyronet, François Ducray, Marc Barritault
Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location. Journal of neuro-oncology 169 (2) (2024)
Tunc Faik Ersoy, Daniel Brainman, Roland Coras, Björn Berger, Florian Weissinger, Alexander Grote, Matthias Simon
Defining the role of surgery for patients with multiple brain metastases. Journal of neuro-oncology 169 (2) (2024)
Sebastian Niedermeyer, M Schmutzer-Sondergeld, J Weller, S Katzendobler, S Kirchleitner, R Forbrig, P N Harter, L V Baumgarten, C Schichor, V Stoecklein, N Thon
Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis. Journal of neuro-oncology 169 (2) (2024)
Maren Strack, Jan Kückelhaus, Martin Diebold, Patrick Wuchter, Peter E Huber, Oliver Schnell, Roman Sankowski, Marco Prinz, Anca-Ligia Grosu, Dieter Henrik Heiland, Nils H Nicolay, Alexander Rühle
Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells. Journal of neuro-oncology 169 (2) (2024)

volume 169, number 3, 2024

Beatriz I Fernandez-Gil, Paula Schiapparelli, Juan P Navarro-Garcia de Llano, Andrea Otamendi-Lopez, Maria Jose Ulloa-Navas, Loizos Michaelides, Carla A Vazquez-Ramos, Steven M Herchko, Melissa E Murray, Yesesri Cherukuri, Yan W Asmann, Daniel M Trifiletti, Alfredo Quinones-Hinojosa
Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach. Journal of neuro-oncology 169 (3) (2024)
Jie Zhou, Wenbo Sun, Huan Li, Xiaopeng Song, Dan Xu, Haibo Xu
Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results. Journal of neuro-oncology 169 (3) (2024)
Alberto Iannalfi, Giulia Riva, Sara Lillo, Lucia Ciccone, Giulia Fontana, Silvia Molinelli, Luca Trombetta, Mario Ciocca, Sara Imparato, Mattia Pecorilla, Ester Orlandi
Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes. Journal of neuro-oncology 169 (3) (2024)
Myunghwan Lee, Philipp Karschnia, Yae Won Park, Kaeum Choi, Kyunghwa Han, Seo Hee Choi, Hong In Yoon, Na-Young Shin, Sung Soo Ahn, Joerg-Christian Tonn, Jong Hee Chang, Se Hoon Kim, Seung-Koo Lee
Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance. Journal of neuro-oncology 169 (3) (2024)
David Gomez, Jeffrey J Feng, Stephanie Cheok, Ishan Shah, Holly Dicharry, David J Cote, Robert G Briggs, Gage A Guerra, Racheal Peterson, Bodour Salhia, Josh Neman, Frank Attenello, Frances Chow, Erion K Musabelliu, Gabriel Zada
Incidence of brain metastasis according to patient race and primary cancer origin: a systematic review. Journal of neuro-oncology 169 (3) (2024)
Sydney E Scanlon, Regan M Shanahan, Othman Bin-Alamer, Alexandros Bouras, Milena Mattioli, Sakibul Huq, Constantinos G Hadjipanayis
Sonodynamic therapy for adult-type diffuse gliomas: past, present, and future. Journal of neuro-oncology 169 (3) (2024)
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, Jörg Felsberg, Daniel Picard, Gabriel Leprivier, Marietta Wolter, My Ky Huynh, Marlene B Olivera, Kerstin Kaulich, Lena Häberle, Irene Esposito, Gunnar W Klau, Julia Steinmann, Thomas Beez, Marion Rapp, Michael Sabel, Sascha Dietrich, Marc Remke, Jan F Cornelius, Guido Reifenberger, Nan Qin
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases. Journal of neuro-oncology 169 (3) (2024)
Kyril L Cole, Emma R Earl, Matthew C Findlay, Brandon A Sherrod, Samuel A Tenhoeve, Jessica Kunzman, Donald M Cannon, Wallace Akerley, Lindsay Burt, Seth B Seifert, Matthew Goldman, Randy L Jensen
Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era. Journal of neuro-oncology 169 (3) (2024)
Clayton R Baker, Matthew W Pease, Daniel P Sexton, Andrew Abumoussa, Lola B Chambless
Artificial intelligence innovations in neurosurgical oncology: a narrative review. Journal of neuro-oncology 169 (3) (2024)
David Gomez, Jeffrey J Feng, Stephanie Cheok, Ishan Shah, Holly Dicharry, David J Cote, Robert G Briggs, Gage A Guerra, Racheal Peterson, Bodour Salhia, Josh Neman, Frank Attenello, Frances Chow, Erion K Musabelliu, Gabriel Zada
Incidence of brain metastasis according to patient race and primary cancer origin: a systematic review. Journal of neuro-oncology 169 (3) (2024)
null null, null null, null null
Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study. Journal of neuro-oncology 169 (3) (2024)
Iori Ozono, Shumpei Onishi, Ushio Yonezawa, Akira Taguchi, Novita Ikbar Khairunnisa, Vishwa Jeet Amatya, Fumiyuki Yamasaki, Yukio Takeshima, Nobutaka Horie
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant. Journal of neuro-oncology 169 (3) (2024)
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, Jörg Felsberg, Daniel Picard, Gabriel Leprivier, Marietta Wolter, My Ky Huynh, Marlene B Olivera, Kerstin Kaulich, Lena Häberle, Irene Esposito, Gunnar W Klau, Julia Steinmann, Thomas Beez, Marion Rapp, Michael Sabel, Sascha Dietrich, Marc Remke, Jan F Cornelius, Guido Reifenberger, Nan Qin
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases. Journal of neuro-oncology 169 (3) (2024)
Hidetoshi Shimizu, Yutaro Koide, Shoichi Haimoto, Takahiro Aoyama, Hiroyuki Tachibana, Shingo Hashimoto, Tohru Iwata, Tomoki Kitagawa, Takeshi Kodaira
Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery. Journal of neuro-oncology 169 (3) (2024)
Hailong Du, Jianping Sun, Xiaoliang Wang, Lei Zhao, Xiaosong Liu, Chao Zhang, Feng Wang, Jianliang Wu
FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells. Journal of neuro-oncology 169 (3) (2024)
Mert Karabacak, Pemla Jagtiani, Alejandro Carrasquilla, Ankita Jain, Isabelle M Germano, Konstantinos Margetis
Simplifying synthesis of the expanding glioblastoma literature: a topic modeling approach. Journal of neuro-oncology 169 (3) (2024)
Iori Ozono, Shumpei Onishi, Ushio Yonezawa, Akira Taguchi, Novita Ikbar Khairunnisa, Vishwa Jeet Amatya, Fumiyuki Yamasaki, Yukio Takeshima, Nobutaka Horie
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant. Journal of neuro-oncology 169 (3) (2024)
Clayton R Baker, Matthew W Pease, Daniel P Sexton, Andrew Abumoussa, Lola B Chambless
Artificial intelligence innovations in neurosurgical oncology: a narrative review. Journal of neuro-oncology 169 (3) (2024)
Pavel S Pichardo-Rojas, Diego Pichardo-Rojas, Luis A Marín-Castañeda, Mariali Palacios-Cruz, Yareli I Rivas-Torres, Luisa F Calderón-Magdaleno, Claudia D Sánchez-Serrano, Ankush Chandra, Antonio Dono, Philipp Karschnia, Joerg-Christian Tonn, Yoshua Esquenazi
Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis. Journal of neuro-oncology 169 (3) (2024)
Alexandre Roux, Marc Zanello, Johan Pallud
Comment on "Clinical course after Carmustine wafer implantation for newly-diagnosed adult-type diffuse gliomas; a controlled propensity matched analysis of a single center cohort". Journal of neuro-oncology 169 (3) (2024)
Wojciech K Panek, R G Toedebusch, Bridget E McLaughlin, Peter J Dickinson, J E Van Dyke, Kevin D Woolard, Michael E Berens, Maciej S Lesniak, B K Sturges, Karen M Vernau, C Li, Jason M Miska, Christine M Toedebusch
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues. Journal of neuro-oncology 169 (3) (2024)
JeongMan Park, Yu Jin Kim, Minwook Lee, Dongkil Kim, JeongMin Sim, Kyunggi Cho, Ju Hyung Moon, Kyoung Su Sung, Dong Hyeon Lee, Jaejoon Lim
Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis. Journal of neuro-oncology 169 (3) (2024)
Suchet Taori, Othman Bin-Alamer, Anthony Tang, Ajay Niranjan, John C Flickinger, Constantinos G Hadjipanayis, L Dade Lunsford
Repeat stereotactic radiosurgery for progressive vestibular schwannomas after primary gamma knife radiosurgery. Journal of neuro-oncology 169 (3) (2024)
Wojciech K Panek, R G Toedebusch, Bridget E McLaughlin, Peter J Dickinson, J E Van Dyke, Kevin D Woolard, Michael E Berens, Maciej S Lesniak, B K Sturges, Karen M Vernau, C Li, Jason M Miska, Christine M Toedebusch
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues. Journal of neuro-oncology 169 (3) (2024)
Suchet Taori, Othman Bin-Alamer, Anthony Tang, Ajay Niranjan, John C Flickinger, Constantinos G Hadjipanayis, L Dade Lunsford
Repeat stereotactic radiosurgery for progressive vestibular schwannomas after primary gamma knife radiosurgery. Journal of neuro-oncology 169 (3) (2024)
Ana-Alicia Beltran-Bless, Bader Alshamsan, Jason Jia, Victor Lo, Seth Climans, Garth Nicholas, Terry L Ng
Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation- a patient and physician survey. Journal of neuro-oncology 169 (3) (2024)
Clayton R Baker, Matthew W Pease, Daniel P Sexton, Andrew Abumoussa, Lola B Chambless
Artificial intelligence innovations in neurosurgical oncology: a narrative review. Journal of neuro-oncology 169 (3) (2024)
Amit Mahajan, Sarah L Goldberg, Sarah A Weiss, Thuy Tran, Kanwar Singh, Kavita Joshi, Mariam S Aboian, Harriet M Kluger, Veronica L Chiang
Patterns of brain metastases response to immunotherapy with pembrolizumab. Journal of neuro-oncology 169 (3) (2024)
Marcio Yuri Ferreira, Maria Antônia O M Pereira, Matheus Hemais, Jhon E Bocanegra-Becerra, Lidia Cheidde, Gustavo de Oliveira Almeida, Ana B Santos, Anthony Hong, Igor Menezes Rocha, Lucca B Palavani, Allan Dias Polverini, Raphael Bertani, Souvik Singha, Christian Ferreira, John A Boockvar
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis. Journal of neuro-oncology 169 (3) (2024)
Iori Ozono, Shumpei Onishi, Ushio Yonezawa, Akira Taguchi, Novita Ikbar Khairunnisa, Vishwa Jeet Amatya, Fumiyuki Yamasaki, Yukio Takeshima, Nobutaka Horie
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant. Journal of neuro-oncology 169 (3) (2024)
Wojciech K Panek, R G Toedebusch, Bridget E McLaughlin, Peter J Dickinson, J E Van Dyke, Kevin D Woolard, Michael E Berens, Maciej S Lesniak, B K Sturges, Karen M Vernau, C Li, Jason M Miska, Christine M Toedebusch
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues. Journal of neuro-oncology 169 (3) (2024)
Suchet Taori, Othman Bin-Alamer, Anthony Tang, Ajay Niranjan, John C Flickinger, Constantinos G Hadjipanayis, L Dade Lunsford
Repeat stereotactic radiosurgery for progressive vestibular schwannomas after primary gamma knife radiosurgery. Journal of neuro-oncology 169 (3) (2024)
Jason P Sheehan, Cheng-Chia Lee, Camilo E Fadul
Progression versus pseudoprogression: radiological differentiation with contrast clearance analysis on brain MRI. Journal of neuro-oncology 169 (3) (2024)
null null, null null, null null
Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study. Journal of neuro-oncology 169 (3) (2024)
null null, null null, null null
Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study. Journal of neuro-oncology 169 (3) (2024)
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, Jörg Felsberg, Daniel Picard, Gabriel Leprivier, Marietta Wolter, My Ky Huynh, Marlene B Olivera, Kerstin Kaulich, Lena Häberle, Irene Esposito, Gunnar W Klau, Julia Steinmann, Thomas Beez, Marion Rapp, Michael Sabel, Sascha Dietrich, Marc Remke, Jan F Cornelius, Guido Reifenberger, Nan Qin
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases. Journal of neuro-oncology 169 (3) (2024)
David Gomez, Jeffrey J Feng, Stephanie Cheok, Ishan Shah, Holly Dicharry, David J Cote, Robert G Briggs, Gage A Guerra, Racheal Peterson, Bodour Salhia, Josh Neman, Frank Attenello, Frances Chow, Erion K Musabelliu, Gabriel Zada
Incidence of brain metastasis according to patient race and primary cancer origin: a systematic review. Journal of neuro-oncology 169 (3) (2024)